| Lantheus Holdings, Inc | $6.5b | $109.25 | +0.6% | 899.0K | |
| Immunome, Inc. | $2.5b | $19.87 | +3.0% | 1.6M | |
| AbCellera Biologics Inc. Common Shares | $1.9b | $7.40 | +10.7% | 13.6M | |
| Aktis Oncology, Inc. Common stock | $1.1b | $29.75 | -5.6% | 665.5K | |
| Alpha Tau Medical Ltd. Ordinary Shares | $1.0b | $10.95 | -2.2% | 451.4K | |
| Crescent Biopharma, Inc. Common Stock | $0.6b | $17.99 | +8.0% | 350.4K | |
| Perspective Therapeutics, Inc. | $449.3m | $3.07 | +1.3% | 2.6M | |
| PLUS THERAPEUTICS, Inc. Common Stock | $40.1m | $4.20 | -0.8% | 234.8K | |
| Actinium Pharmaceuticals, Inc | $39.5m | $0.98 | +4.2% | 101.4K | |
| American Shared Hospital Services | $9.7m | $1.60 | +1.3% | 358.4K | |
| iTonic Holdings Ltd Class A Ordinary Shares | $5.1m | $0.31 | -2.9% | 30.8K |